Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cubist Pharmaceuticals Inc (CBST)    
$101.94 0.00 (0.00%) as of 4:30 Wed 1/21


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 76,000,000 as of 12/25
Market Cap: 7.75(B)
Last Volume: 8,007,632 Avg Vol: 1,171,725
52 Week Range: $60.5 - $101.94
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  738
Guru Rank Value     : 2
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Co. has three marketed products: CUBICIN® (daptomycin for injection), a once-daily, bactericidal, intravenous antibiotic with activity against certain Gram-positive organisms; ENTEREG (alvimopan), an oral, peripherally-acting mu opioid receptor antagonist approved to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis; and DIFICID (fidaxomicin) for the treatment of clostridium difficile-associated diarrhea.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 96,863 341,690 895,698
Total Sell Value $0 $6,346,471 $24,819,702 $55,636,841
Total People Sold 0 5 9 12
Total Sell Transactions 0 5 28 79
End Date 2014-10-30 2014-07-29 2014-01-28 2013-01-28

   
Records found: 664
  Page 1 of 27  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Corrigan Mark Director   –       •      –    2015-01-21 4 D $102.00 $765,102 D/D (7,501) 0     -
   Bonney Michael W Chief Executive Officer   •       •      –    2015-01-21 4 D $102.00 $756,432 I/I (7,416) 0     -
   Perez Robert J Chief Executive Officer   •       •      –    2015-01-21 4 D $102.00 $4,827,150 D/D (47,325) 0     -
   Perez Robert J Chief Executive Officer   •       •      –    2015-01-21 4 D $102.00 $511,224 I/I (5,012) 0     -
   Lawton Alison Francis Director   –       •      –    2015-01-21 4 D $102.00 $481,134 D/D (4,717) 0     -
   Hutson Nancy J Director   –       •      –    2015-01-21 4 D $102.00 $607,002 D/D (5,951) 0     -
   Vink Patrick V.j.j. EVP and COO   •       –      –    2015-01-21 4 D $102.00 $560,592 D/D (5,496) 0     -
   Bate Kenneth Director   –       •      –    2015-01-21 4 D $102.00 $980,730 D/D (9,615) 0     -
   Gilman Steven C EVP & Chief Scientific Officer   •       –      –    2015-01-21 4 D $102.00 $3,114,162 D/D (30,531) 0     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       –      –    2015-01-21 4 D $102.00 $812,634 D/D (7,967) 0     -
   Soeters Martinus Hermanus Director   –       •      –    2015-01-21 4 D $102.00 $1,060,494 D/D (10,397) 0     -
   Moulder Leon O Jr Director   –       •      –    2015-01-21 4 D $102.00 $1,132,302 D/D (11,101) 0     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       –      –    2015-01-21 4 D $102.00 $122,298 I/I (1,199) 0     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       –      –    2015-01-21 4 D $102.00 $1,506,030 D/D (14,765) 0     -
   Henney Jane E Md Director   –       •      –    2015-01-21 4 D $102.00 $473,688 D/D (4,644) 0     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       –      –    2015-01-21 4 D $102.00 $48,858 I/I (479) 0     -
   Bonney Michael W Chief Executive Officer   •       •      –    2015-01-21 4 D $102.00 $17,975,052 D/D (176,226) 0     -
   Desrosier Thomas SVP, Chief Legal Officer & GC   •       •      –    2014-12-31 4 A $42.59 $11,841 D/D 278 278     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-12-31 4 A $59.96 $8,874 D/D 148 7,967     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-12-31 4 A $59.96 $4,917 D/D 82 27,680     -
   Perez Robert J Chief Executive Officer   •       •      –    2014-12-31 4 A $59.96 $1,919 D/D 32 47,357     -
   Desrosier Thomas EVP, Chief Legal OfficerAdmini   •       –      –    2014-12-29 4 D $100.71 $1,206,304 D/D (11,978) 7,819     -
   Desrosier Thomas EVP, Chief Legal OfficerAdmini   •       –      –    2014-12-29 4 OE $45.90 $825,053 D/D 17,975 19,797     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       –      –    2014-12-29 4 D $100.71 $1,144,771 D/D (11,367) 14,765     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       –      –    2014-12-29 4 OE $23.50 $470,000 D/D 20,000 26,132     -

  664 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 27
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed